Loading organizations...
§ Private Profile · Paris, Ile-de-France, France
AI software company developing deep learning for radiology, automating fracture and chest pathology detection on X-rays for hospitals.
Based in Paris, France, AZmed develops artificial intelligence software that automates fracture detection and chest pathology analysis in standard medical X-rays for the radiology and healthcare sectors. The company operates on a B2B SaaS model, deploying its flagship Rayvolve diagnostic platform to more than 1,000 healthcare facilities and hospitals across over 40 countries. Supported by a workforce of more than 100 employees, the enterprise has secured both European CE mark and United States FDA clearance for its deep learning medical imaging technology. AZmed has raised approximately €17 million in total disclosed funding, which includes a €15 million Series A round in early 2024 backed by institutional investors such as Cathay Health, Techstars, Bpifrance, and the European Innovation Council. The organization was originally founded in 2018 by Julien Vidal, Alexandre Attia, and Dr. Elie Zerbib.
AZmed has raised $16.2M across 1 funding round.
AZmed has raised $16.2M in total across 1 funding round.
AZmed has raised $16.2M in total across 1 funding round.
AZmed's investors include Arnaud Decrulle, Teampact Ventures, Techstars.
AZmed has raised $16.2M across 1 funding round. Most recently, it raised $16.2M Series A in February 2024.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Feb 20, 2024 | $16.2M Series A | — | Arnaud Decrulle, Teampact Ventures, Techstars | Announced |